Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents.
Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG, Stadtmauer EA, Loren AW.
Kim GYG, et al. Among authors: schuster mg.
Am J Hematol. 2020 Jul;95(7):792-798. doi: 10.1002/ajh.25808. Epub 2020 May 4.
Am J Hematol. 2020.
PMID: 32242967
Free article.